elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
STAT3
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
STAT3
RIS
0.004
(Research Intensity Score)
Papers
408
Top papers
Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma
2025 · 109 citations
Unveiling the link between chronic inflammation and cancer
2025 · 75 citations
Sustained release of magnesium and zinc ions synergistically accelerates wound healing
2023 · 180 citations
IL-4 and IL-13 induce equivalent expression of traditional M2 markers and modulation of reactive oxygen species in human macrophages
2023 · 96 citations
Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion
2020 · 432 citations
Newest papers
Smart nanoparticle delivery systems for curcumin: a targeted strategy to enhance anticancer efficacy and bioavailability
2026 · 11 citations
Transient mechanical activation of the Piezo1 channel facilitates ex vivo expansion of hematopoietic stem cells
2026 · 5 citations
Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma
2025 · 109 citations
Unveiling the link between chronic inflammation and cancer
2025 · 75 citations
Interactions between atrial fibrosis and inflammation in atrial fibrillation
2025 · 18 citations
A sample from the 100 top papers behind STAT3.
Create a free account to browse them all →
STAT3's history
Research intensity over time
Explore STAT3's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
STAT3's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link